4,147 reports of this reaction
1.0% of all ADAPALENE reports
#16 most reported adverse reaction
RASH PAPULAR is the #16 most commonly reported adverse reaction for ADAPALENE, manufactured by Alchemee, LLC. There are 4,147 FDA adverse event reports linking ADAPALENE to RASH PAPULAR. This represents approximately 1.0% of all 416,192 adverse event reports for this drug.
Patients taking ADAPALENE who experience rash papular should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH PAPULAR is a less commonly reported adverse event for ADAPALENE, but still significant enough to appear in the safety profile.
In addition to rash papular, the following adverse reactions have been reported for ADAPALENE:
The following drugs have also been linked to rash papular in FDA adverse event reports:
RASH PAPULAR has been reported as an adverse event in 4,147 FDA reports for ADAPALENE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH PAPULAR accounts for approximately 1.0% of all adverse event reports for ADAPALENE, making it a notable side effect.
If you experience rash papular while taking ADAPALENE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.